Global Solid Tumor Drugs Market Professional Survey Report 2017




This report studies Solid Tumor Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering AstraZeneca Abbott Laboratories Amgen Limited & Amgen Ireland Limited Biogen Baxter Bristol-Myers Squibb Company F. Hoffmann-La Roche Eli Lilly and Company Johnson & Johnson GlaxoSmithKline Celgene Corporation Pfizer On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into Small Molecules Enzymes Blood and Blood Components Gene Therapy Recombinant Proteins Somatic Cells Tissues Vaccines By Application, the market can be split into Oncology Radiology Neurology Others By Regions, this report covers (we can add the regions/countries as you want) North America China Europe Southeast Asia Japan India If you have any special requirements, please let us know and we will offer you the report as you want.


Table of Contents

Global Solid Tumor Drugs Market Professional Survey Report 2017
1 Industry Overview of Solid Tumor Drugs
    1.1 Definition and Specifications of Solid Tumor Drugs
        1.1.1 Definition of Solid Tumor Drugs
        1.1.2 Specifications of Solid Tumor Drugs
    1.2 Classification of Solid Tumor Drugs
        1.2.1 Small Molecules
        1.2.2 Enzymes
        1.2.3 Blood and Blood Components
        1.2.4 Gene Therapy
        1.2.5 Recombinant Proteins
        1.2.6 Somatic Cells
        1.2.7 Tissues
        1.2.8 Vaccines
    1.3 Applications of Solid Tumor Drugs
        1.3.1 Oncology
        1.3.2 Radiology
        1.3.3 Neurology
        1.3.4 Others
    1.4 Market Segment by Regions
        1.4.1 North America
        1.4.2 China
        1.4.3 Europe
        1.4.4 Southeast Asia
        1.4.5 Japan
        1.4.6 India

2 Manufacturing Cost Structure Analysis of Solid Tumor Drugs
    2.1 Raw Material and Suppliers
    2.2 Manufacturing Cost Structure Analysis of Solid Tumor Drugs
    2.3 Manufacturing Process Analysis of Solid Tumor Drugs
    2.4 Industry Chain Structure of Solid Tumor Drugs

3 Technical Data and Manufacturing Plants Analysis of Solid Tumor Drugs
    3.1 Capacity and Commercial Production Date of Global Solid Tumor Drugs Major Manufacturers in 2016
    3.2 Manufacturing Plants Distribution of Global Solid Tumor Drugs Major Manufacturers in 2016
    3.3 R&D Status and Technology Source of Global Solid Tumor Drugs Major Manufacturers in 2016
    3.4 Raw Materials Sources Analysis of Global Solid Tumor Drugs Major Manufacturers in 2016

4 Global Solid Tumor Drugs Overall Market Overview
    4.1 2012-2017E Overall Market Analysis
    4.2 Capacity Analysis
        4.2.1 2012-2017E Global Solid Tumor Drugs Capacity and Growth Rate Analysis
        4.2.2 2016 Solid Tumor Drugs Capacity Analysis (Company Segment)
    4.3 Sales Analysis
        4.3.1 2012-2017E Global Solid Tumor Drugs Sales and Growth Rate Analysis
        4.3.2 2016 Solid Tumor Drugs Sales Analysis (Company Segment)
    4.4 Sales Price Analysis
        4.4.1 2012-2017E Global Solid Tumor Drugs Sales Price
        4.4.2 2016 Solid Tumor Drugs Sales Price Analysis (Company Segment)

5 Solid Tumor Drugs Regional Market Analysis
    5.1 North America Solid Tumor Drugs Market Analysis
        5.1.1 North America Solid Tumor Drugs Market Overview
        5.1.2 North America 2012-2017E Solid Tumor Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.1.3 North America 2012-2017E Solid Tumor Drugs Sales Price Analysis
        5.1.4 North America 2016 Solid Tumor Drugs Market Share Analysis
    5.2 China Solid Tumor Drugs Market Analysis
        5.2.1 China Solid Tumor Drugs Market Overview
        5.2.2 China 2012-2017E Solid Tumor Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.2.3 China 2012-2017E Solid Tumor Drugs Sales Price Analysis
        5.2.4 China 2016 Solid Tumor Drugs Market Share Analysis
    5.3 Europe Solid Tumor Drugs Market Analysis
        5.3.1 Europe Solid Tumor Drugs Market Overview
        5.3.2 Europe 2012-2017E Solid Tumor Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.3.3 Europe 2012-2017E Solid Tumor Drugs Sales Price Analysis
        5.3.4 Europe 2016 Solid Tumor Drugs Market Share Analysis
    5.4 Southeast Asia Solid Tumor Drugs Market Analysis
        5.4.1 Southeast Asia Solid Tumor Drugs Market Overview
        5.4.2 Southeast Asia 2012-2017E Solid Tumor Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.4.3 Southeast Asia 2012-2017E Solid Tumor Drugs Sales Price Analysis
        5.4.4 Southeast Asia 2016 Solid Tumor Drugs Market Share Analysis
    5.5 Japan Solid Tumor Drugs Market Analysis
        5.5.1 Japan Solid Tumor Drugs Market Overview
        5.5.2 Japan 2012-2017E Solid Tumor Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.5.3 Japan 2012-2017E Solid Tumor Drugs Sales Price Analysis
        5.5.4 Japan 2016 Solid Tumor Drugs Market Share Analysis
    5.6 India Solid Tumor Drugs Market Analysis
        5.6.1 India Solid Tumor Drugs Market Overview
        5.6.2 India 2012-2017E Solid Tumor Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.6.3 India 2012-2017E Solid Tumor Drugs Sales Price Analysis
        5.6.4 India 2016 Solid Tumor Drugs Market Share Analysis

6 Global 2012-2017E Solid Tumor Drugs Segment Market Analysis (by Type)
    6.1 Global 2012-2017E Solid Tumor Drugs Sales by Type
    6.2 Different Types of Solid Tumor Drugs Product Interview Price Analysis
    6.3 Different Types of Solid Tumor Drugs Product Driving Factors Analysis
        6.3.1 Small Molecules of Solid Tumor Drugs Growth Driving Factor Analysis
        6.3.2 Enzymes of Solid Tumor Drugs Growth Driving Factor Analysis
        6.3.3 Blood and Blood Components of Solid Tumor Drugs Growth Driving Factor Analysis
        6.3.4 Gene Therapy of Solid Tumor Drugs Growth Driving Factor Analysis
        6.3.5 Recombinant Proteins of Solid Tumor Drugs Growth Driving Factor Analysis
        6.3.6 Somatic Cells of Solid Tumor Drugs Growth Driving Factor Analysis
        6.3.7 Tissues of Solid Tumor Drugs Growth Driving Factor Analysis
        6.3.8 Vaccines of Solid Tumor Drugs Growth Driving Factor Analysis

7 Global 2012-2017E Solid Tumor Drugs Segment Market Analysis (by Application)
    7.1 Global 2012-2017E Solid Tumor Drugs Consumption by Application
    7.2 Different Application of Solid Tumor Drugs Product Interview Price Analysis
    7.3 Different Application of Solid Tumor Drugs Product Driving Factors Analysis
        7.3.1 Oncology of Solid Tumor Drugs Growth Driving Factor Analysis
        7.3.2 Radiology of Solid Tumor Drugs Growth Driving Factor Analysis
        7.3.3 Neurology of Solid Tumor Drugs Growth Driving Factor Analysis
        7.3.4 Others of Solid Tumor Drugs Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Solid Tumor Drugs
    8.1 AstraZeneca
        8.1.1 Company Profile
        8.1.2 Product Picture and Specifications
            8.1.2.1 Product A
            8.1.2.2 Product B
        8.1.3 AstraZeneca 2016 Solid Tumor Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.1.4 AstraZeneca 2016 Solid Tumor Drugs Business Region Distribution Analysis
    8.2 Abbott Laboratories
        8.2.1 Company Profile
        8.2.2 Product Picture and Specifications
            8.2.2.1 Product A
            8.2.2.2 Product B
        8.2.3 Abbott Laboratories 2016 Solid Tumor Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.2.4 Abbott Laboratories 2016 Solid Tumor Drugs Business Region Distribution Analysis
    8.3 Amgen Limited & Amgen Ireland Limited
        8.3.1 Company Profile
        8.3.2 Product Picture and Specifications
            8.3.2.1 Product A
            8.3.2.2 Product B
        8.3.3 Amgen Limited & Amgen Ireland Limited 2016 Solid Tumor Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.3.4 Amgen Limited & Amgen Ireland Limited 2016 Solid Tumor Drugs Business Region Distribution Analysis
    8.4 Biogen
        8.4.1 Company Profile
        8.4.2 Product Picture and Specifications
            8.4.2.1 Product A
            8.4.2.2 Product B
        8.4.3 Biogen 2016 Solid Tumor Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.4.4 Biogen 2016 Solid Tumor Drugs Business Region Distribution Analysis
    8.5 Baxter
        8.5.1 Company Profile
        8.5.2 Product Picture and Specifications
            8.5.2.1 Product A
            8.5.2.2 Product B
        8.5.3 Baxter 2016 Solid Tumor Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.5.4 Baxter 2016 Solid Tumor Drugs Business Region Distribution Analysis
    8.6 Bristol-Myers Squibb Company
        8.6.1 Company Profile
        8.6.2 Product Picture and Specifications
            8.6.2.1 Product A
            8.6.2.2 Product B
        8.6.3 Bristol-Myers Squibb Company 2016 Solid Tumor Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.6.4 Bristol-Myers Squibb Company 2016 Solid Tumor Drugs Business Region Distribution Analysis
    8.7 F. Hoffmann-La Roche
        8.7.1 Company Profile
        8.7.2 Product Picture and Specifications
            8.7.2.1 Product A
            8.7.2.2 Product B
        8.7.3 F. Hoffmann-La Roche 2016 Solid Tumor Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.7.4 F. Hoffmann-La Roche 2016 Solid Tumor Drugs Business Region Distribution Analysis
    8.8 Eli Lilly and Company
        8.8.1 Company Profile
        8.8.2 Product Picture and Specifications
            8.8.2.1 Product A
            8.8.2.2 Product B
        8.8.3 Eli Lilly and Company 2016 Solid Tumor Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.8.4 Eli Lilly and Company 2016 Solid Tumor Drugs Business Region Distribution Analysis
    8.9 Johnson & Johnson
        8.9.1 Company Profile
        8.9.2 Product Picture and Specifications
            8.9.2.1 Product A
            8.9.2.2 Product B
        8.9.3 Johnson & Johnson 2016 Solid Tumor Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.9.4 Johnson & Johnson 2016 Solid Tumor Drugs Business Region Distribution Analysis
    8.10 GlaxoSmithKline
        8.10.1 Company Profile
        8.10.2 Product Picture and Specifications
            8.10.2.1 Product A
            8.10.2.2 Product B
        8.10.3 GlaxoSmithKline 2016 Solid Tumor Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.10.4 GlaxoSmithKline 2016 Solid Tumor Drugs Business Region Distribution Analysis
    8.11 Celgene Corporation
    8.12 Pfizer

9 Development Trend of Analysis of Solid Tumor Drugs Market
    9.1 Global Solid Tumor Drugs Market Trend Analysis
        9.1.1 Global 2017-2022 Solid Tumor Drugs Market Size (Volume and Value) Forecast
        9.1.2 Global 2017-2022 Solid Tumor Drugs Sales Price Forecast
    9.2 Solid Tumor Drugs Regional Market Trend
        9.2.1 North America 2017-2022 Solid Tumor Drugs Consumption Forecast
        9.2.2 China 2017-2022 Solid Tumor Drugs Consumption Forecast
        9.2.3 Europe 2017-2022 Solid Tumor Drugs Consumption Forecast
        9.2.4 Southeast Asia 2017-2022 Solid Tumor Drugs Consumption Forecast
        9.2.5 Japan 2017-2022 Solid Tumor Drugs Consumption Forecast
        9.2.6 India 2017-2022 Solid Tumor Drugs Consumption Forecast
    9.3 Solid Tumor Drugs Market Trend (Product Type)
    9.4 Solid Tumor Drugs Market Trend (Application)

10 Solid Tumor Drugs Marketing Type Analysis
    10.1 Solid Tumor Drugs Regional Marketing Type Analysis
    10.2 Solid Tumor Drugs International Trade Type Analysis
    10.3 Traders or Distributors with Contact Information of Solid Tumor Drugs by Region
    10.4 Solid Tumor Drugs Supply Chain Analysis

11 Consumers Analysis of Solid Tumor Drugs
    11.1 Consumer 1 Analysis
    11.2 Consumer 2 Analysis
    11.3 Consumer 3 Analysis
    11.4 Consumer 4 Analysis

12 Conclusion of the Global Solid Tumor Drugs Market Professional Survey Report 2017
    Methodology
    Analyst Introduction
    Data Source



List of Tables and Figures
    Figure Picture of Solid Tumor Drugs
    Table Product Specifications of Solid Tumor Drugs
    Table Classification of Solid Tumor Drugs
    Figure Global Production Market Share of Solid Tumor Drugs by Type in 2016
    Figure Small Molecules Picture
    Table Major Manufacturers of Small Molecules
    Figure Enzymes Picture
    Table Major Manufacturers of Enzymes
    Figure Blood and Blood Components Picture
    Table Major Manufacturers of Blood and Blood Components
    Figure Gene Therapy Picture
    Table Major Manufacturers of Gene Therapy
    Figure Recombinant Proteins Picture
    Table Major Manufacturers of Recombinant Proteins
    Figure Somatic Cells Picture
    Table Major Manufacturers of Somatic Cells
    Figure Tissues Picture
    Table Major Manufacturers of Tissues
    Figure Vaccines Picture
    Table Major Manufacturers of Vaccines
    Table Applications of Solid Tumor Drugs
    Figure Global Consumption Volume Market Share of Solid Tumor Drugs by Application in 2016
    Figure Oncology Examples
    Table Major Consumers in Oncology
    Figure Radiology Examples
    Table Major Consumers in Radiology
    Figure Neurology Examples
    Table Major Consumers in Neurology
    Figure Others Examples
    Table Major Consumers in Others
    Figure Market Share of Solid Tumor Drugs by Regions
    Figure North America Solid Tumor Drugs Market Size (Million USD) (2012-2022)
    Figure China Solid Tumor Drugs Market Size (Million USD) (2012-2022)
    Figure Europe Solid Tumor Drugs Market Size (Million USD) (2012-2022)
    Figure Southeast Asia Solid Tumor Drugs Market Size (Million USD) (2012-2022)
    Figure Japan Solid Tumor Drugs Market Size (Million USD) (2012-2022)
    Figure India Solid Tumor Drugs Market Size (Million USD) (2012-2022)
    Table Solid Tumor Drugs Raw Material and Suppliers
    Table Manufacturing Cost Structure Analysis of Solid Tumor Drugs in 2016
    Figure Manufacturing Process Analysis of Solid Tumor Drugs
    Figure Industry Chain Structure of Solid Tumor Drugs
    Table Capacity and Commercial Production Date of Global Solid Tumor Drugs Major Manufacturers in 2016
    Table Manufacturing Plants Distribution of Global Solid Tumor Drugs Major Manufacturers in 2016
    Table R&D Status and Technology Source of Global Solid Tumor Drugs Major Manufacturers in 2016
    Table Raw Materials Sources Analysis of Global Solid Tumor Drugs Major Manufacturers in 2016
    Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Solid Tumor Drugs 2012-2017
    Figure Global 2012-2017E Solid Tumor Drugs Market Size (Volume) and Growth Rate
    Figure Global 2012-2017E Solid Tumor Drugs Market Size (Value) and Growth Rate
    Table 2012-2017E Global Solid Tumor Drugs Capacity and Growth Rate
    Table 2016 Global Solid Tumor Drugs Capacity (K Units) List (Company Segment)
    Table 2012-2017E Global Solid Tumor Drugs Sales (K Units) and Growth Rate
    Table 2016 Global Solid Tumor Drugs Sales (K Units) List (Company Segment)
    Table 2012-2017E Global Solid Tumor Drugs Sales Price (USD/Unit)
    Table 2016 Global Solid Tumor Drugs Sales Price (USD/Unit) List (Company Segment)
    Figure North America Capacity Overview
    Table North America Supply, Import, Export and Consumption (K Units) of Solid Tumor Drugs 2012-2017E 
    Figure North America 2012-2017E Solid Tumor Drugs Sales Price (USD/Unit)
    Figure North America 2016 Solid Tumor Drugs Sales Market Share
    Figure China Capacity Overview
    Table China Supply, Import, Export and Consumption (K Units) of Solid Tumor Drugs 2012-2017E 
    Figure China 2012-2017E Solid Tumor Drugs Sales Price (USD/Unit) 
    Figure China 2016 Solid Tumor Drugs Sales Market Share
    Figure Europe Capacity Overview
    Table Europe Supply, Import, Export and Consumption (K Units) of Solid Tumor Drugs 2012-2017E
    Figure Europe 2012-2017E Solid Tumor Drugs Sales Price (USD/Unit)
    Figure Europe 2016 Solid Tumor Drugs Sales Market Share
    Figure Southeast Asia Capacity Overview
    Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Solid Tumor Drugs 2012-2017E
    Figure Southeast Asia 2012-2017E Solid Tumor Drugs Sales Price (USD/Unit)
    Figure Southeast Asia 2016 Solid Tumor Drugs Sales Market Share
    Figure Japan Capacity Overview
    Table Japan Supply, Import, Export and Consumption (K Units) of Solid Tumor Drugs 2012-2017E
    Figure Japan 2012-2017E Solid Tumor Drugs Sales Price (USD/Unit)
    Figure Japan 2016 Solid Tumor Drugs Sales Market Share
    Figure India Capacity Overview
    Table India Supply, Import, Export and Consumption (K Units) of Solid Tumor Drugs 2012-2017E
    Figure India 2012-2017E Solid Tumor Drugs Sales Price (USD/Unit)
    Figure India 2016 Solid Tumor Drugs Sales Market Share
    Table Global 2012-2017E Solid Tumor Drugs Sales (K Units) by Type
    Table Different Types Solid Tumor Drugs Product Interview Price
    Table Global 2012-2017E Solid Tumor Drugs Sales (K Units) by Application
    Table Different Application Solid Tumor Drugs Product Interview Price
    Table AstraZeneca Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 AstraZeneca Solid Tumor Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2016 AstraZeneca Solid Tumor Drugs Business Region Distribution
    Table Abbott Laboratories Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 Abbott Laboratories Solid Tumor Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2016 Abbott Laboratories Solid Tumor Drugs Business Region Distribution
    Table Amgen Limited & Amgen Ireland Limited Information List
    Table Product A Overview
    Table Product B Overview
    Table 2015 Amgen Limited & Amgen Ireland Limited Solid Tumor Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2016 Amgen Limited & Amgen Ireland Limited Solid Tumor Drugs Business Region Distribution
    Table Biogen Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 Biogen Solid Tumor Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2016 Biogen Solid Tumor Drugs Business Region Distribution
    Table Baxter Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 Baxter Solid Tumor Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2016 Baxter Solid Tumor Drugs Business Region Distribution
    Table Bristol-Myers Squibb Company Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 Bristol-Myers Squibb Company Solid Tumor Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2016 Bristol-Myers Squibb Company Solid Tumor Drugs Business Region Distribution
    Table F. Hoffmann-La Roche Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 F. Hoffmann-La Roche Solid Tumor Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2016 F. Hoffmann-La Roche Solid Tumor Drugs Business Region Distribution
    Table Eli Lilly and Company Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 Eli Lilly and Company Solid Tumor Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2016 Eli Lilly and Company Solid Tumor Drugs Business Region Distribution
    Table Johnson & Johnson Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 Johnson & Johnson Solid Tumor Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2016 Johnson & Johnson Solid Tumor Drugs Business Region Distribution
    Table GlaxoSmithKline Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 GlaxoSmithKline Solid Tumor Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2016 GlaxoSmithKline Solid Tumor Drugs Business Region Distribution
    Table Celgene Corporation Information List
    Table Pfizer Information List
    Figure Global 2017-2022 Solid Tumor Drugs Market Size (K Units) and Growth Rate Forecast
    Figure Global 2017-2022 Solid Tumor Drugs Market Size (Million USD) and Growth Rate Forecast
    Figure Global 2017-2022 Solid Tumor Drugs Sales Price (USD/Unit) Forecast
    Figure North America 2017-2022 Solid Tumor Drugs Consumption Volume (K Units) and Growth Rate Forecast
    Figure China 2017-2022 Solid Tumor Drugs Consumption Volume (K Units) and Growth Rate Forecast
    Figure Europe 2017-2022 Solid Tumor Drugs Consumption Volume (K Units) and Growth Rate Forecast
    Figure Southeast Asia 2017-2022 Solid Tumor Drugs Consumption Volume (K Units) and Growth Rate Forecast
    Figure Japan 2017-2022 Solid Tumor Drugs Consumption Volume (K Units) and Growth Rate Forecast
    Figure India 2017-2022 Solid Tumor Drugs Consumption Volume (K Units) and Growth Rate Forecast
    Table Global Sales Volume (K Units) of Solid Tumor Drugs by Type 2017-2022
    Table Global Consumption Volume (K Units) of Solid Tumor Drugs by Application 2017-2022
    Table Traders or Distributors with Contact Information of Solid Tumor Drugs by Region


Let our analyst help you with a customized solution for your market research needs

Select the license

Credit card Logo
hkjkhjkhjkhjkmjhjhkhjkjkhjkhjkm
Discount  Check Discount Question  Any Questions
hkjkhjkhjkhjkmjhjhkhjkjkhjkhjkm
fgfhfhfgf